BioVigilant Systems Inc. Submits Drug Master Files to FDA, Accelerating Regulatory Approval Process for Instantaneous Microbial Detection Equipment Use

TUCSON, Ariz.--(BUSINESS WIRE)--BioVigilant Systems, Inc. (www.biovigilant.com), inventors of Instantaneous Microbial Detection, today announced that the Company has submitted two Type V Drug Master Files (DMFs) to the U.S. Food and Drug Administration (FDA) for its IMD(TM)-A product line, a family of products used for rapid environmental air monitoring in pharmaceutical environments. In support of customers’ filings, these DMFs may now be referenced by pharmaceutical drug manufacturers who wish to use BioVigilant’s systems in FDA-regulated applications.